Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000247502 | SCV000320138 | likely benign | Cardiovascular phenotype | 2015-10-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000586204 | SCV000532734 | likely benign | not provided | 2019-08-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586204 | SCV000700057 | benign | not provided | 2016-05-02 | criteria provided, single submitter | clinical testing | Variant summary: The c.978T>C variant affects a non-conserved nucleotide, resulting in a synonymous change. 4/5 splice-tools in Alamut predict that this variant does not affect normal splicing. ESE finder predicts changes of binding motifs for splicing enhancers. However, these predictions have not been validated via functional studies. This variant is found in 5/121384 control chromosomes at a frequency of 0.0000412, which is about 4 times of the maximal expected frequency of a pathogenic allele (0.00001), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant was classified as benign. |
Labcorp Genetics |
RCV001086312 | SCV001005169 | likely benign | Brugada syndrome 4 | 2024-01-17 | criteria provided, single submitter | clinical testing |